Design, synthesis and biological evaluation of new thalidomide analogues as TNF-alpha and IL-6 production inhibitors

  • Chaulet, Charlotte
  • Croix, Cecile
  • Alagille, David
  • Normand, Sylvain
  • Delwail, Adriana
  • Favot, Laure
  • Lecron, Jean-Claude
  • Viaud-Massuard, Marie-Claude
Publication date
February 2011
Publisher
Elsevier BV

Abstract

International audienceSeveral thalidomide analogues were synthesized and compared to thalidomide and its more active analogue, lenalidomide, for their ability to inhibit the production of the pro-inflammatory cytokine tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 by LPS-activated peripheral blood mononuclear cells (PBMCs). Among these compounds, two analogues containing sulfonyl group displayed interesting downregulation of TNF-alpha and IL-6 production. (C) 2010 Elsevier Ltd. All rights reserved

Extracted data

We use cookies to provide a better user experience.